恒瑞医药
(600276)
| 流通市值：4021.32亿 | | | 总市值：4184.09亿 |
| 流通股本：63.79亿 | | | 总股本：66.37亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 40,364,073,830.44 | 36,121,847,258.77 | 24,085,707,596.26 | 24,815,905,657.75 |
| 交易性金融资产 | 111,451,738.49 | 109,008,426.17 | 110,116,290.63 | 273,344,684.37 |
| 应收票据及应收账款 | 5,215,314,138.87 | 5,138,420,424.32 | 4,969,902,835.85 | 5,064,745,008.65 |
| 其中：应收票据 | 119,926,761.39 | 115,871,584.3 | 140,335,876.67 | 149,872,397.37 |
| 应收账款 | 5,095,387,377.48 | 5,022,548,840.02 | 4,829,566,959.18 | 4,914,872,611.28 |
| 应收款项融资 | 1,006,795,080.85 | 895,205,451.39 | 2,328,588,810.09 | 1,094,724,979.82 |
| 预付款项 | 1,434,115,084.05 | 1,474,856,580.62 | 1,575,752,612.45 | 1,147,239,443.44 |
| 其他应收款合计 | 41,500,309.05 | 42,650,250.66 | 40,956,660.61 | 66,413,247.5 |
| 存货 | 2,740,688,248.38 | 2,581,065,230.17 | 2,400,981,547.8 | 2,417,118,478.12 |
| 其他流动资产 | 485,599,435.38 | 397,235,182.78 | 457,759,544.21 | 435,435,740.94 |
| 流动资产合计 | 51,399,537,865.51 | 46,760,288,804.88 | 35,969,765,897.9 | 35,314,927,240.59 |
| 非流动资产: | | | | |
| 长期股权投资 | 610,854,242.82 | 624,887,093.36 | 641,505,864.1 | 666,353,806.05 |
| 其他非流动金融资产 | 1,171,708,744.84 | 1,190,105,605.91 | 1,065,208,108.97 | 1,065,410,856.58 |
| 固定资产 | 5,050,433,737.79 | 5,146,618,900.44 | 5,114,649,340.89 | 5,131,973,616.64 |
| 在建工程 | 2,299,553,729.64 | 1,991,958,379.2 | 1,868,359,243.7 | 1,687,525,956.97 |
| 使用权资产 | 84,902,753.34 | 92,138,056.5 | 101,609,466.07 | 108,663,501.72 |
| 无形资产 | 1,455,206,802.65 | 1,400,322,179.73 | 1,381,172,987.37 | 1,192,307,211.5 |
| 开发支出 | 4,818,460,489.67 | 4,367,240,897.81 | 3,940,044,814.83 | 3,837,558,941.33 |
| 长期待摊费用 | 215,965,945.8 | 242,929,300.61 | 257,121,132.57 | 274,642,793.52 |
| 递延所得税资产 | 497,835,597.07 | 409,874,399.32 | 415,437,575.75 | 377,174,628.6 |
| 其他非流动资产 | 723,080,576.65 | 667,153,530.78 | 537,907,258.76 | 479,106,750.6 |
| 非流动资产合计 | 16,928,002,620.27 | 16,133,228,343.66 | 15,323,015,793.01 | 14,820,718,063.51 |
| 资产总计 | 68,327,540,485.78 | 62,893,517,148.54 | 51,292,781,690.91 | 50,135,645,304.1 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 2,224,775,256.98 | 2,199,446,687.16 | 1,997,125,437.72 | 1,967,259,141.2 |
| 应付账款 | 2,224,775,256.98 | 2,199,446,687.16 | 1,997,125,437.72 | 1,967,259,141.2 |
| 合同负债 | 3,971,298,591.4 | 161,335,626.51 | 162,694,388.21 | 159,793,447.59 |
| 应付职工薪酬 | 5,429,443.19 | 5,388,909.03 | 5,104,075.67 | 4,921,404.37 |
| 应交税费 | 514,972,004.29 | 428,063,883.92 | 439,199,705.67 | 426,994,059.62 |
| 其他应付款合计 | 1,100,841,851.83 | 622,611,075.81 | 709,525,702.6 | 1,029,985,142.5 |
| 一年内到期的非流动负债 | 31,023,287.53 | 45,956,342.46 | 45,956,342.46 | 41,125,925.62 |
| 其他流动负债 | 3,248,380.69 | 2,246,018.12 | 3,275,841.77 | 3,516,601.77 |
| 流动负债合计 | 7,851,588,815.91 | 3,465,048,543.01 | 3,362,881,494.1 | 3,633,595,722.67 |
| 非流动负债: | | | | |
| 租赁负债 | 51,415,500.07 | 45,472,633.28 | 62,712,297.71 | 69,036,137.59 |
| 递延收益 | 258,441,262.54 | 224,791,191.65 | 216,369,535.04 | 225,650,466.9 |
| 递延所得税负债 | 133,576,904.39 | 128,406,741.46 | 101,049,306.32 | 117,112,243.63 |
| 非流动负债合计 | 443,433,667 | 398,670,566.39 | 380,131,139.07 | 411,798,848.12 |
| 负债合计 | 8,295,022,482.91 | 3,863,719,109.4 | 3,743,012,633.17 | 4,045,394,570.79 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 6,637,199,874 | 6,637,199,874 | 6,379,002,274 | 6,379,002,274 |
| 资本公积 | 12,932,037,269.66 | 12,871,496,724.29 | 2,853,874,760.58 | 3,188,072,621.03 |
| 减:库存股 | 1,743,124,931.17 | 1,427,696,973.93 | 1,303,731,185.49 | 1,228,624,448.88 |
| 其他综合收益 | 36,658,209.45 | 43,414,380.36 | 19,417,101.61 | 16,970,393.77 |
| 盈余公积 | 3,298,912,011.55 | 3,298,912,011.55 | 3,298,912,011.55 | 3,298,912,011.55 |
| 未分配利润 | 38,342,568,353.7 | 37,041,505,200.51 | 35,739,584,528.83 | 33,865,529,008.85 |
| 归属于母公司股东权益合计 | 59,504,250,787.19 | 58,464,831,216.78 | 46,987,059,491.08 | 45,519,861,860.32 |
| 少数股东权益 | 528,267,215.68 | 564,966,822.36 | 562,709,566.66 | 570,388,872.99 |
| 股东权益合计 | 60,032,518,002.87 | 59,029,798,039.14 | 47,549,769,057.74 | 46,090,250,733.31 |
| 负债和股东权益合计 | 68,327,540,485.78 | 62,893,517,148.54 | 51,292,781,690.91 | 50,135,645,304.1 |
| 公告日期 | 2025-10-28 | 2025-08-21 | 2025-04-25 | 2025-03-31 |
| 审计意见(境内) | | | | 标准无保留意见 |